Mr. Caracciolo has served as CytoDyn’s Chairman of the Board since June 2013 and Director since December 2011. He has more than 38 years of experience in the pharmaceutical sciences industry. Previously, he served for 13 years at Gilead Sciences, Inc., a publicly traded research-based biopharmaceutical company, prior to his retirement in 2010. Among his positions at Gilead, he was Senior Vice President, Manufacturing and Operations, and a senior member of that company’s executive committee.